Rita El‐Khoueiry

706 total citations
38 papers, 534 citations indexed

About

Rita El‐Khoueiry is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rita El‐Khoueiry has authored 38 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Rita El‐Khoueiry's work include Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (11 papers) and Gastric Cancer Management and Outcomes (8 papers). Rita El‐Khoueiry is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (11 papers) and Gastric Cancer Management and Outcomes (8 papers). Rita El‐Khoueiry collaborates with scholars based in United States, Japan and Austria. Rita El‐Khoueiry's co-authors include Dongyun Yang, Armin Gerger, Melissa J. LaBonte, Heinz‐Josef Lenz, Pierre Bohanes, Léonor Benhaïm, Yan Ning, David Páez, Takeru Wakatsuki and Wu Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Rita El‐Khoueiry

37 papers receiving 526 citations

Peers

Rita El‐Khoueiry
Rita El‐Khoueiry
Citations per year, relative to Rita El‐Khoueiry Rita El‐Khoueiry (= 1×) peers Yuichi Hisamatsu

Countries citing papers authored by Rita El‐Khoueiry

Since Specialization
Citations

This map shows the geographic impact of Rita El‐Khoueiry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita El‐Khoueiry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita El‐Khoueiry more than expected).

Fields of papers citing papers by Rita El‐Khoueiry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita El‐Khoueiry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita El‐Khoueiry. The network helps show where Rita El‐Khoueiry may publish in the future.

Co-authorship network of co-authors of Rita El‐Khoueiry

This figure shows the co-authorship network connecting the top 25 collaborators of Rita El‐Khoueiry. A scholar is included among the top collaborators of Rita El‐Khoueiry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita El‐Khoueiry. Rita El‐Khoueiry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Yan, Diana L. Hanna, Wu Zhang, et al.. (2015). Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach. Molecular Cancer Therapeutics. 14(10). 2401–2408. 22 indexed citations
2.
Stremitzer, Stefan, W. Zhang, Dongyun Yang, et al.. (2015). Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastases. Annals of Oncology. 26(8). 1728–1733. 12 indexed citations
3.
Stremitzer, Stefan, Anna S. Berghoff, W. Zhang, et al.. (2015). Genetic variants associated with colorectal brain metastases susceptibility and survival. The Pharmacogenomics Journal. 17(1). 29–35. 9 indexed citations
4.
Stremitzer, Stefan, Yu Sunakawa, Wei Zhang, et al.. (2015). Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases. The Pharmacogenomics Journal. 15(6). 521–529. 16 indexed citations
5.
Stremitzer, Stefan, Sebastian Stintzing, Volker Heinemann, et al.. (2015). Variations in Y chromosome-related genes and clinical outcome in metastatic colorectal cancer.. Journal of Clinical Oncology. 33(3_suppl). 634–634. 1 indexed citations
6.
Bohanes, Pierre, Dongyun Yang, Fotios Loupakis, et al.. (2014). Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer. The Pharmacogenomics Journal. 15(3). 226–234. 12 indexed citations
7.
Sunakawa, Yu, Stefan Stremitzer, Shu Cao, et al.. (2014). Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer. Annals of Oncology. 26(2). 332–339. 28 indexed citations
8.
Benhaïm, Léonor, W Zhang, Takeru Wakatsuki, et al.. (2014). Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer. The Pharmacogenomics Journal. 15(3). 235–240. 2 indexed citations
9.
Loupakis, Fotios, Carlotta Antoniotti, Chiara Cremolini, et al.. (2014). Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients. The Pharmacogenomics Journal. 14(4). 322–327. 9 indexed citations
10.
Sunakawa, Yu, Takeru Wakatsuki, Dongyun Yang, et al.. (2014). Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients. Pharmacogenetics and Genomics. 24(12). 588–596. 10 indexed citations
11.
Stintzing, Sebastian, W Zhang, Dongyun Yang, et al.. (2014). Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer. The Pharmacogenomics Journal. 15(1). 69–76. 26 indexed citations
12.
Sunakawa, Yu, Fotios Loupakis, Dongyun Yang, et al.. (2014). CCL2 polymorphism as a predictive marker for bevacizumab (Bev) in combination with FOLFIRI as first-line treatment in metastatic colorectal cancer (mCRC) patients (pts).. Journal of Clinical Oncology. 32(15_suppl). e14556–e14556. 1 indexed citations
13.
Wakatsuki, Takeru, Melissa J. LaBonte, Pierre Bohanes, et al.. (2013). Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States. Molecular Cancer Therapeutics. 12(10). 2261–2272. 18 indexed citations
14.
Ning, Yan, Armin Gerger, Wu Zhang, et al.. (2013). Plastin Polymorphisms Predict Gender- and Stage-Specific Colon Cancer Recurrence after Adjuvant Chemotherapy. Molecular Cancer Therapeutics. 13(2). 528–539. 34 indexed citations
15.
Benhaïm, Léonor, Armin Gerger, Pierre Bohanes, et al.. (2013). Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy. The Pharmacogenomics Journal. 14(2). 135–141. 10 indexed citations
17.
Bohanes, Pierre, Dongyun Yang, Melissa J. LaBonte, et al.. (2012). Influence of Sex on the Survival of Patients With Esophageal Cancer. Journal of Clinical Oncology. 30(18). 2265–2272. 109 indexed citations
18.
Loupakis, Fotios, Wu Zhang, Armin Gerger, et al.. (2012). LMTK3 polymorphism in patients with metastatic colon cancer.. Journal of Clinical Oncology. 30(4_suppl). 471–471. 4 indexed citations
19.
Gerger, Armin, Anthony B. El-Khoueiry, Wu Zhang, et al.. (2011). Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 17(17). 5783–5792. 72 indexed citations
20.
LaBonte, Melissa J., P. M. Wilson, Dongyun Yang, et al.. (2011). The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer. Annals of Oncology. 23(6). 1455–1464. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026